Improving the safety of tolerance induction: Chimerism and cellular co-treatment strategies applied to vascularized composite allografts

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Huang, Wei Chao ^a,b   Lin, Jeng Yee ^b,c   Wallace, Christopher Glenn ^d   Wei, Fu Chan ^d   Liao, Shuen Kuei ^b,c  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; AZATHIOPRINE; B7 ANTIGEN; BASILIXIMAB; CD28 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; CD86 ANTIGEN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; DACLIZUMAB; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD 2; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; RAPAMYCIN; T LYMPHOCYTE ANTIBODY; T LYMPHOCYTE RECEPTOR; TACROLIMUS; THYMOCYTE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACUTE GRAFT REJECTION; ALLOGENIC BONE MARROW TRANSPLANTATION; ALLOGRAFT; ANTIGEN PRESENTING CELL; BONE GRAFT; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL THERAPY; CHIMERA; CHRONIC GRAFT REJECTION; CORTICOSTEROID THERAPY; DENDRITIC CELL; DRUG EFFICACY; DRUG SAFETY; ENGRAFTMENT; FLOW CYTOMETRY; GRAFT RECIPIENT; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; IRRADIATION; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; NONHUMAN; ORGAN DONOR; ORGAN TRANSPLANTATION; PATIENT SAFETY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; REVIEW; RISK FACTOR; T CELL DEPLETION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TREATMENT INDICATION; VASCULARIZED COMPOSITE ALLOGRAFT; ALLOTRANSPLANTATION; ANIMAL; HISTOCOMPATIBILITY; IMMUNOLOGY; TRANSPLANTATION TOLERANCE;

ANIMALS; BONE MARROW TRANSPLANTATION; CHIMERISM; HUMANS; TRANSPLANTATION CHIMERA; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 84868682900     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/107901     Document Type: Review

References (76)

1. Strome M., Stein J., Esclamado R., Hicks D., Lorenz R. R., Braun W., Yetman R., Eliachar I., Mayes J., Laryngeal transplantation and 40-moth follow-up. New England Journal of Medicine 2001 344 22 1676 1679 2-s2.0-0035978728 10.1056/NEJM200105313442204 (Pubitemid 32479965)
2. Dubernard J. M., Owen E., Herzberg G., Martin X., Guigal V., Dawahra M., Pasticier G., Mongin-Long D., Kopp C., Ostapetz A., Lanzetta M., Kapila H., Hakim N., First hand allograft. Early results. Chirurgie 1999 124 4 358 367 2-s2.0-0033195883 10.1016/S0001-4001(00)80007-0 (Pubitemid 29482067)
3. Cooney W. P., Hentz V. R., Successful hand transplantationone-year follow-up. New England Journal of Medicine 2001 344 1 65 66 2-s2.0-0035804285 10.1056/NEJM200101043440116
4. Jones J. W., Gruber S. A., Barker J. H., Breidenbach W. C., Successful hand transplantation: one-year follow-up. New England Journal of Medicine 2000 343 7 468 473 2-s2.0-0034680052 10.1056/NEJM200008173430704 (Pubitemid 30646486)
5. Dubernard J. M., Lengelé B., Morelon E., Testelin S., Badet L., Moure C., Beziat J. L., Dakpé S., Kanitakis J., D'Hauthuille C., El Jaafari A., Petruzzo P., Lefrancois N., Taha F., Sirigu A., Di Marco G., Carmi E., Bachmann D., Cremades S., Giraux P., Burloux G., Hequet O., Parquet N., Francès C., Michallet M., Martin X., Devauchelle B., Outcomes 18 months after the first human partial face transplantation. New England Journal of Medicine 2007 357 24 2451 2460 2-s2.0-37249018015 10.1056/NEJMoa072828 (Pubitemid 350272784)
6. Barker J. H., Francois C. G., Frank J. M., Maldonado C., Composite tissue allotransplantation. Transplantation 2002 73 5 832 835 2-s2.0-0037087757 (Pubitemid 34260589)
7. Majzoub R. K., Cunningham M., Grossi F., Maldonado C., Banis J. C., Barker J. H., Investigation of risk acceptance in hand transplantation. Journal of Hand Surgery 2006 31 2 295 302 2-s2.0-32444448246 10.1016/j.jhsa.2005.09.013 (Pubitemid 43227283)
8. Bakr M. A., Induction therapy. Experimental & Clinical Transplantation 2005 3 1 320 328
9. Brock M. V., Borja M. C., Ferber L., Orens J. B., Anzcek R. A., Krishnan J., Yang S. C., Conte J. V., Induction therapy in lung transplantation: a prospective, controlled clinical trial comparing OKT3, anti-thymocyte globulin, and daclizumab. Journal of Heart and Lung Transplantation 2001 20 12 1282 1290 2-s2.0-0035660725 10.1016/S1053-2498(01)00356-4 (Pubitemid 34017313)
10. Wagner S. J., Brennan D. C., Induction therapy in renal transplant recipients: How convincing is the current evidence? Drugs 2012 72 5 671 683 2-s2.0-84858782546 10.2165/11631300-000000000-00000
11. Matthews J. B., Ramos E., Bluestone J. A., Clinical trials of transplant tolerance: slow but steady progress. American Journal of Transplantation 2003 3 7 794 803 2-s2.0-0038690324 10.1046/j.1600-6135.2003.0154.x (Pubitemid 36827901)
12. Baluja P., Haragsim L., Laszik Z., Chronic allograft nephropathy. Advances in Chronic Kidney Disease 2006 13 1 56 61 2-s2.0-30444452230 10.1053/j.ackd.2005.11.004 (Pubitemid 43075445)
13. Korngold R., Sprent J., Lethal graft versus host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow. Journal of Experimental Medicine 1978 148 6 1687 1698 2-s2.0-0018257740 (Pubitemid 9084041)
14. Ghayur T., Seemayer T. A., Lapp W. S., Kinetics of natural killer cell cytotoxicity during the graft-versus-host reaction. Relationship between natural killer cell activity, T and B cell activity, and development of histopathological alterations. Transplantation 1987 44 2 254 260 2-s2.0-0023618303 (Pubitemid 17148083)
15. Fugier-Vivier I. J., Rezzoug F., Huang Y., Graul-Layman A. J., Schanie C. L., Xu H., Chilton P. M., Ildstad S. T., Plasmacytoid precursor dendritic cells facilitate allogeneic hematopoietic stem cell engraftment. Journal of Experimental Medicine 2005 201 3 373 383 2-s2.0-13644256027 10.1084/jem.20041399 (Pubitemid 40229412)
16. Fang B., Song Y. P., Liao L. M., Han Q., Zhao R. C., Treatment of severe therapy-resistant acute graft-versus-host disease with human adipose tissue-derived mesenchymal stem cells. Bone Marrow Transplantation 2006 38 5 389 390 2-s2.0-33747371731 10.1038/sj.bmt.1705457
17. Itakura S., Asari S., Rawson J., Ito T., Todorov I., Liu C. P., Sasaki N., Kandeel F., Mullen Y., Mesenchymal stem cells facilitate the induction of mixed hematopoietic chimerism and islet allograft tolerance without GVHD in the rat. American Journal of Transplantation 2007 7 2 336 346 2-s2.0-33846217749 10.1111/j.1600-6143.2006.01643.x (Pubitemid 46096326)
18. Huang Y., Cramer D. E., Ray M. B., Chilton P. M., Que X., Ildstad S. T., The role of α β-and γ δ -T cells in allogeneic donor marrow on engraftment, chimerism, and graft-versus-host disease. Transplantation 2001 72 12 1907 1914 2-s2.0-0035543766 (Pubitemid 34027862)
19. Jacquet E. G., Schanie C. L., Fugier-Vivier I., Willer S. S., Ildstad S. T., Facilitating cells as a venue to establish mixed chimerism and tolerance. Pediatric Transplantation 2003 7 5 348 357 2-s2.0-0142086674 10.1034/j.1399-3046.2003.00100.x (Pubitemid 37295940)
20. + regulatory T cells. Journal of Immunology 2004 173 7 4433 4442 2-s2.0-4644327023 (Pubitemid 39280673)
21. Gilliet M., Liu Y. J., Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. Journal of Experimental Medicine 2002 195 6 695 704 2-s2.0-0037128654 10.1084/jem.20011603 (Pubitemid 34259715)
22. Huang W. C., Lin J. Y., Wei F. C., Liao S. K., Induction of tolerance through mixed chimerism for composite tissue allotransplantation: insights, problems and solutions. Tzu Chi Medical Journal 2008 20 2 101 108 2-s2.0-44849143369 10.1016/S1016-3190(08)60018-X (Pubitemid 351798251)
23. Gorantla V. S., Prabhune K. A., Perez-Abadia G., Ildstad S. T., Maldonado C., Orhun H. I., Majzoub R. K., Francois C. G., Kakoulidis T. P., Brouha P. C. R., Anderson G. L., Pidwell D. J., Breidenbach W. C., Barker J. H., Composite tissue allotransplantation in chimeric hosts: part I. Prevention of graft-versus-host disease. Transplantation 2003 75 7 922 932 2-s2.0-0037446825 (Pubitemid 36438517)
24. Brouha P. C. R., Perez-Abadia G., Francois C. G., Laurentin-Perez L. A., Gorantla V., Vossen M., Tai C., Pidwell D., Anderson G. L., Stadelmann W. K., Hewitt C. W., Kon M., Barker J. H., Maldonado C., Lymphadenectomy prior to rat hind limb allotransplantation prevents graft-versus-host disease in chimeric hosts. Transplant International 2004 17 7 341 350 2-s2.0-4544374143 10.1111/j.1432-2277.2004.tb00453.x (Pubitemid 39222593)
25. Lanzetta M., Nolli R., Borgonovo A., Owen E. R., Dubernard J. M., Kapila H., Martin X., Hakim N., Dawahra M., Hand transplantation: ethics, immunosuppression and indications. Journal of Hand Surgery 2001 26 6 511 516 2-s2.0-0035710867 10.1054/jhsb.2001.0635 (Pubitemid 34149916)
26. Walsh P. T., Taylor D. K., Turka L. A., Tregs and transplantation tolerance. Journal of Clinical Investigation 2004 114 10 1398 1403 2-s2.0-15244352325 10.1172/JCI200423238 (Pubitemid 40385567)
27. Prabhune K. A., Gorantla V. S., Maldonado C., Perez-Abadia G., Barker J. H., Ildstad S. T., Mixed allogeneic chimerism and tolerance to composite tissue allografts. Microsurgery 2000 20 8 441 447 2-s2.0-0035884428 10.1002/1098-2752(2000)20:8441::AID-MICR16>3.0.CO;2-A (Pubitemid 32044153)
28. Ildstad S. T., Wren S. M., Bluestone J. A., Characterization of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity, and genetic specificity of tolerance. Journal of Experimental Medicine 1985 162 1 231 244 2-s2.0-0021845739 (Pubitemid 15029899)
29. Sykes M., Shimizu I., Kawahara T., Mixed hematopoietic chimerism for the simultaneous induction of T and B cell tolerance. Transplantation 2005 79 supplement 3 S28 S29 2-s2.0-14344264156 10.1097/01.TP.0000153296.80385.E7 (Pubitemid 40293570)
30. Huang W. C., Lin J. Y., Wallace C. G., Chuang W. Y., Wei F. C., Liao S. K., Vascularized bone grafts within composite tissue allotransplants can autocreate tolerance through mixed chimerism with partial myeloablative conditioning: an experimental study in rats. Plastic and Reconstructive Surgery 2010 125 4 1095 1103 2-s2.0-77951042808 10.1097/PRS.0b013e3181d0ab80
31. Kawai T., Cosimi A. B., Spitzer T. R., Tolkoff-Rubin N., Suthanthiran M., Saidman S. L., Shaffer J., Preffer F. I., Ding R., Sharma V., Fishman J. A., Dey B., Ko D. S. C., Hertl M., Goes N. B., Wong W., Williams W. W., Colvin R. B., Sykes M., Sachs D. H., HLA-mismatched renal transplantation without maintenance immunosuppression. New England Journal of Medicine 2008 358 4 353 361 2-s2.0-38549088096 10.1056/NEJMoa071074 (Pubitemid 351159234)
32. Starzl T. E., Demetris A. J., Murase N., Ildstad S., Ricordi C., Trucco M., Cell migration, chimerism, and graft acceptance. The Lancet 1992 339 8809 1579 1582 2-s2.0-0026691478 10.1016/0140-6736(92)91840-5
33. Charbord P., The hematopoietic stem cell and the stromal microenvironment. Therapie 2001 56 383 384 (Pubitemid 32923878)
34. + T-Cell depletion and rapamycin synergize with combined coreceptor/stimulation blockade to induce robust limb allograft tolerance in mice. American Journal of Transplantation 2008 8 12 2527 2536 2-s2.0-55949090901 10.1111/j.1600-6143.2008.02419.x
35. Rahhal D. N., Xu H., Huang W. C., Wu S., Wen Y., Huang Y., Ildstad S. T., Dissociation between peripheral blood chimerism and tolerance to hindlimb composite tissue transplants: preferential localization of chimerism in donor bone. Transplantation 2009 88 6 773 781 2-s2.0-70350543645 10.1097/TP. 0b013e3181b47cfa
36. Thomas J. M., Eckhoff D. E., Contreras J. L., Lobashevsky A. L., Hubbard W. J., Moore J. K., Cook W. J., Thomas F. T., Neville D. M., Durable donor-specific T and B cell tolerance in rhesus macaques induced with peritransplantation anti-CD3 immunotoxin and deoxyspergualin: absence of chronic allograft nephropathy. Transplantation 2000 69 12 2497 2503 2-s2.0-33747872037 (Pubitemid 30482014)
37. Hirose R., Vincenti F., Immunosuppression: today, tomorrow, and withdrawal. Seminars in Liver Disease 2006 26 3 201 210 2-s2.0-33746547309 10.1055/s-2006-947290 (Pubitemid 44141927)
38. Mariat C., Alamartine E., Diab N., de Filippis J. P., Laurent B., Berthoux F., A randomized prospective study comparing low-dose OKT3 to low-dose ATG for the treatment of acute steroid-resistant rejection episodes in kidney transplant recipients. Transplant International 1998 11 3 231 236 2-s2.0-0031838098 10.1007/s001470050133 (Pubitemid 28239378)
39. Kirk A. D., Hale D. A., Mannon R. B., Kleiner D. E., Hoffmann S. C., Kampen R. L., Cendales L. K., Tadaki D. K., Harlan D. M., Swanson J., Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (Campath-1H). Transplantation 2003 76 1 120 129 2-s2.0-0038638396 (Pubitemid 36877125)
40. Siemionow M. Z., Izycki D. M., Zielinski M., Donor-specific tolerance in fully major histocompatibility complex-mismatched limb allograft transplants under an anti- α β T-cell receptor monoclonal antibody and cyclosporine a protocol. Transplantation 2003 76 12 1662 1668 2-s2.0-0347993687 10.1097/01.TP.0000105343.49626.6F (Pubitemid 38032410)
41. Siemionow M., Klimczak A., Unal S., Agaoglu G., Carnevale K., Hematopoietic stem cell engraftment and seeding permits multi-lymphoid chimerism in vascularized bone marrow transplants. American Journal of Transplantation 2008 8 6 1163 1176 2-s2.0-44449160961 10.1111/j.1600-6143.2008.02241.x (Pubitemid 351763693)
42. Zhu Z. X., Fan L. Y., Wang Q., Simultaneous blockade of costimulatory signals CD28-CD80 and CD40-CD154 combined with monoclonal antibody against CD25 induced a stable chimerism and tolerance without Graft-versus-Host disease in rat. European Surgical Research 2011 46 3 109 117 2-s2.0-78651380632 10.1159/000323011
43. Haspot F., Séveno C., Dugast A. S., Coulon F., Renaudin K., Usal C., Hill M., Anegon I., Heslan M., Josien R., Brouard S., Soulillou J. P., Vanhove B., Anti-CD28 antibody-induced kidney allograft tolerance related to tryptophan degradation and TCR- class II- B7+ regulatory cells. American Journal of Transplantation 2005 5 10 2339 2348 2-s2.0-33644686064 10.1111/j.1600-6143. 2005.01018.x
44. Durham M. M., Bingaman A. W., Adams A. B., Ha J., Waitze S. Y., Pearson T. C., Larsen C. P., Cutting edge: administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning. Journal of Immunology 2000 165 1 1 4 2-s2.0-0034235458 (Pubitemid 30429481)
45. Foster R. D., Pham S., Li S., Aitouche A., Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade. Transplantation 2003 76 6 988 994 2-s2.0-0141433187 10.1097/01.TP.0000079827. 91675.A3 (Pubitemid 37186033)
46. Wekerle T., Kurtz J., Ito H., Ronquillo J. V., Dong V., Zhao G., Shaffer J., Sayegh M. H., Sykes M., Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nature Medicine 2000 6 4 464 469 2-s2.0-0034071426 10.1038/74731 (Pubitemid 30208167)
47. Blaha P., Bigenzahn S., Koporc Z., Schmid M., Langer F., Selzer E., Bergmeister H., Wrba F., Kurtz J., Kiss C., Roth E., Muehlbacher F., Sykes M., Wekerle T., The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade. Blood 2003 101 7 2886 2893 2-s2.0-0038576227 10.1182/blood-2002-10-3014 (Pubitemid 36857658)
48. Graca L., Daley S., Fairchild P. J., Cobbold S. P., Waldmann H., Co-receptor and co-stimulation blockade for mixed chimerism and tolerance without myelosuppressive conditioning. BMC Immunology 2006 7, article 9 2-s2.0-33646671989 10.1186/1471-2172-7-9 (Pubitemid 43733030)
49. Mellor A. L., Baban B., Chandler P., Marshall B., Jhaver K., Hansen A., Koni P. A., Iwashima M., Munn D. H., Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion. Journal of Immunology 2003 171 4 1652 1655 2-s2.0-0042591467 (Pubitemid 36966447)
50. Dai W., Gupta S. L., Molecular cloning, sequencing and expression of human interferon- γ -inducible indoleamine 2,3-dioxygenase cDNA. Biochemical and Biophysical Research Communications 1990 168 1 1 8 2-s2.0-0025320803 (Pubitemid 20142577)
51. Wilson N. S., El-Sukkari D., Belz G. T., Smith C. M., Steptoe R. J., Heath W. R., Shortman K., Villadangos J. A., Most lymphoid organ dendritic cell types are phenotypically and functionally immature. Blood 2003 102 6 2187 2194 2-s2.0-0141678970 10.1182/blood-2003-02-0513 (Pubitemid 37122397)
52. Belz G. T., Heath W. R., Carbone F. R., The role of dendritic cell subsets in selection between tolerance and immunity. Immunology and Cell Biology 2002 80 5 463 468 2-s2.0-0036380917 10.1046/j.1440-1711.2002.01116.x
53. Barratt-Boyes S. M., Thomson A. W., Dendritic cells: tools and targets for transplant tolerance. American Journal of Transplantation 2005 5 12 2807 2813 2-s2.0-33644818052 10.1111/j.1600-6143.2005.01116.x (Pubitemid 43923940)
54. + T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells. Journal of Immunology 2004 172 7 4100 4110 2-s2.0-1642396607 (Pubitemid 38375222)
55. Mirenda V., Berton I., Read J., Cook T., Smith J., Dorling A., Lechler R. I., Modified dendritic cells coexpressing self and allogeneic major histocompatability complex molecules: an efficient way to induce indirect pathway regulation. Journal of the American Society of Nephrology 2004 15 4 987 997 2-s2.0-1642403899 10.1097/01.ASN.0000119575.98696.1D (Pubitemid 38375317)
56. Ghetu N., Huang W. C., Tay S. K. L., et a, Adipose-derived stem cells facilitate vascularized bone graft within composite tissue allotransplantation to induce transplant tolerancein rat models. Proceedings of the Microsurgery Annual Meeting January 2010 Boca Raton, Fla, USA
57. Blanc K. L., Frassoni F., Ball L., Locatelli F., Roelofs H., Lewis I., Lanino E., Sundberg B., Bernardo M. E., Remberger M., Dini G., Egeler R. M., Bacigalupo A., Fibbe W., Ringdén O., Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. The Lancet 2008 371 9624 1579 1586 2-s2.0-43049103438 10.1016/S0140-6736(08)60690-X (Pubitemid 351626841)
58. Kuo Y. R., Chen C. C., Goto S., Lin P. Y., Wei F. C., Mesenchymal stem cells as immunomodulators in vascularized composite allotransplantation. Clinical and Developmental Immunology. In press
59. Pan H., Zhao K., Wang L., Zheng Y., Zhang G., Mai H., Han Y., Yang L., Guo S., Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation. Journal of Surgical Research 2010 160 2 315 324 2-s2.0-77950918454 10.1016/j.jss.2008. 09.027
60. Lin J. Y., Tsai F. C., Wallace C. G., Huang W. C., Wei F. C., Liao S. K., Optimizing chimerism level through bone marrow transplantation and irradiation to induce long-term tolerane to composite tissue allograft. Journal of Surgical Research. In press
61. Jaeckel E., von Boehmer H., Manns M. P., Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetes. Diabetes 2005 54 2 306 310 2-s2.0-12744262844 10.2337/diabetes.54.2.306
62. + Tregs by TCR gene transfer favors transplantation tolerance in mice. Journal of Clinical Investigation 2008 118 11 3619 3628 2-s2.0-55849142632 10.1172/JCI33185
63. + regulatory T cells promote experimental transplantation tolerance. Blood 2007 109 2 827 835 2-s2.0-33846214275 10.1182/blood-2006-05-025460 (Pubitemid 46105988)
64. + regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nature Medicine 2003 9 9 1144 1150 2-s2.0-0141461418 10.1038/nm915 (Pubitemid 37173698)
65. + immunoregulatory T cells: new therapeutics for graft-versus-host disease. Journal of Experimental Medicine 2002 196 3 401 406 2-s2.0-0037026001 10.1084/jem.20020090 (Pubitemid 34875668)
66. Bluestone J. A., Thomson A. W., Shevach E. M., Weiner H. L., What does the future hold for cell-based tolerogenic therapy? Nature Reviews Immunology 2007 7 8 650 654 2-s2.0-34547150491 10.1038/nri2137 (Pubitemid 47123553)
67. + regulatory T cells. Nature Immunology 2003 4 4 330 336 2-s2.0-0037385330 10.1038/ni904 (Pubitemid 36432314)
68. Pilat N., Baranyi U., Klaus C., Jaeckel E., Mpofu N., Wrba F., Golshayan D., Muehlbacher F., Wekerle T., Treg-therapy allows mixed chimerism and transplantation tolerance without cytoreductive conditioning. American Journal of Transplantation 2010 10 4 751 762 2-s2.0-77949852097 10.1111/j.1600-6143. 2010.03018.x
69. Lin J. Y., Tsai F. C., Wallace C. G., Huang W. C., Wei F. C., Liao S. K., Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning. Journal of Surgical Research. In press
70. Bozulic L. D., Wen Y., Xu H., Ildstad S. T., Evidence that foxP3+ regulatory T cells may play a role in promoting long-term acceptance of composite tissue allotransplants. Transplantation 2011 91 8 908 915 2-s2.0-79954746812 10.1097/TP.0b013e31820fafb4
71. Eljaafari A., Badet L., Kanitakis J., Ferrand C., Farre A., Petruzzo P., Morelon E., Dubosson M., Tiberghien P., Dubois V., Martin X., Miossec P., Dubernard J. M., Isolation of regulatory T cells in the skin of a human hand-allograft, up to six years posttransplantation. Transplantation 2006 82 12 1764 1768 2-s2.0-33845941704 10.1097/01.tp.0000250937.46187.ca (Pubitemid 46035664)
72. Hautz T., Brandacher G., Zelger B., Müller H. G., Lee A. W. P., Fuchs D., Margreiter R., Schneeberger S., Indoleamine 2,3-dioxygenase and foxp3 expression in skin rejection of human hand allografts. Transplantation Proceedings 2009 41 2 509 512 2-s2.0-62849086405 10.1016/j.transproceed.2009.01. 008
73. + regulatory T-cell lines from human cord blood have functional and molecular properties of T-cell anergy. Blood 2005 106 9 3068 3073 2-s2.0-27644503683 10.1182/blood-2005-04-1531 (Pubitemid 41565902)
74. Fujisaki J., Wu J., Carlson A. L., In vivo imaging of T reg cells providing immune privilege to the haematopoietic stem-cell niche. Nature 474 216 219
75. Ghannam S., Bouffi C., Djouad F., Jorgensen C., Noël D. I., Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications. Stem Cell Research and Therapy 2010 1 1, article 2 2-s2.0-77958467862 10.1186/scrt2
76. Chan C.-K., Lee Y.-S., Hwang S.-M., Wu K.-H., Lee M.-S., Liao S.-K., Cheng E.-H., See L.-C., Tsai C.-N., Kuo M.-L., Huang J.-L., The comparison of interleukin 6-associated immunosuppressive effects of human ESCs, fetal-type MSCs, and adult-type MSCs. Transplantation 2012 94 2 132 138 2-s2.0-84864278141